Piper Jaffray Downgrades Impax Laboratories (IPXL) to Neutral
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Wall Street sinks as bond yields rise, Walmart results disappoint
Impax Laboratories (IPXL) Receives DoJ Subpoena
November 7, 2014 8:05 AM ESTOn November 3, 2014, a sales representative of Impax Laboratories (NASDAQ: IPXL) received a subpoena from the Justice Departments Antitrust Division requesting the production of documents to and testimony before the grand jury of the Eastern District of Pennsylvania. The request relates to any communication or... More
Impax Labs (IPXL) Tops Q3 EPS by 2c
November 4, 2014 9:15 AM ESTImpax Labs (NASDAQ: IPXL) reported Q3 EPS of $0.33, $0.02 better than the analyst estimate of $0.31. Revenue for the quarter came in at $158 million versus the consensus estimate of $148.36 million.
For earnings history and earnings-related data on Impax Labs (IPXL) click here.
... More